+ Watch MNKD
on My Watchlist
A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer.
FDA approval of Mankind's new insulin dosing technology will be paradigm shift for diabetes patients. The Dreamboat dosing system requires no needles, is very easy to use, uniquely fast acting (effective blood levels in 14 minutes), safe and effective. Multi-bagger stock potential within 1 yr.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions